SEARCH

SEARCH BY CITATION

REFERENCES

  • Alward WL, McMahon BJ, Hall DB, Heyward WL, Francis DP, Bender TR. 1985. The long-term serological course of asymptomatic hepatitis B virus carriers and the development of primary hepatocellular carcinoma. J Infect Dis 151: 604609.
  • Aritomi T, Yatsuhashi H, Fujino T, Yamasaki K, Inoue O, Koga M, Kato Y, Yano M. 1998. Association of mutations in the core promoter and precore region of hepatitis virus with fulminant and severe acute hepatitis in Japan. J Gastroenterol Hepatol 13: 11251132.
  • Bonino F, Rosina F, Rizzetto M, Rizzi R, Chiaberge E, Tardanico R, Callea F, Verme G. 1986. Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 90: 12681273.
  • Bruss V, Gerlich WH. 1988. Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein. Virology 163: 268275.
  • Buckword VE, Xu Z, Chen M, Yen TS, Ou JH. 1996. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 70: 58455851.
  • Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC. 1989. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2: 588591.
  • Garcia PD, Ou JH, Rutter WJ, Walter P. 1988. Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: After signal peptide cleavage translocation can be aborted and the product released into the cytoplasm. J Cell Biol 106: 10931104.
  • Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB. 1981. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 94: 744748.
  • Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Liaw YF. 2002. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35: 15221527.
  • Ikeda K, Arase Y, Kobayashi M, Someya T, Saitoh S, Suzuki Y, Suzuki F, Tsubota A, Akuta N, Kumada H. 2003. Consistently low hepatitis B virus DNA saves patients from hepatocellular carcinogenesis in HBV-related cirrhosis. A nested case-control study using 96 untreated patients. Intervirology 46: 96104.
  • Kessler HH, Pierer K, Dragon E, Lackner H, Santner B, Stunzner D, Stelzl E, Waitzl B, Marth E. 1998. Evaluation of a new assay for HBV DNA quantitation in patients with chronic hepatitis B. Clin Diagn Virol 9: 3743.
  • Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, Maki N. 2002. Sensitive enzyme-immunoassay for hepatitis B virus core-related antigen and their correlation to virus load. J Clin Microbiol 40: 439445.
  • Kosaka Y, Takase K, Kojima M, Shimizu M, Inoue K, Yoshiba M, Tanaka S, Akahane Y, Okamoto H, Tsuda F, Miyakawa Y, Mayumi M. 1991. Fulminant HBV: Induction by hepatitis B virus mutants defective in the precore region and incapable of encoding e-antigen. Gastroenterology 100: 10871093.
  • Lee WM. 1997. Hepatitis B virus infection. N Engl J Med 337: 17331745.
  • Liaw YF, Chu CM, Su IJ, Huang MJ, Lin DY, Chang-Chien CS. 1983. Clinical and histological events preceding hepatitis B e antigen seroconversion to antibody in chronic type B hepatitis. Gastroenterology 84: 216219.
  • Lindh M, Gustavson C, Mardberg K, Norkrans G, Dhillon AP, Horal P. 1998. Mutation of nucleotide 1762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers. J Med Virol 55: 185190.
  • Lok ASF, Lai CL, Wu PC, Leung EKY, Lam TS. 1987. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology 92: 18391843.
  • Maddrey WC. 2000. Hepatitis B: An important public health issue. J Med Virol 61: 362366.
  • Maynard JE. 1990. . Hepatitis B: Global importance and need for control. Vaccine: S18S320.
  • McMahon BJ, Holck P, Bulkow L, Snowball M. 2001. Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus. Ann Intern Med 135: 759768.
  • Mizokami M, Nakano T, Orito E, Tanaka Y, Sakugawa H, Mukaide M, Robertson BH, 1999. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns. FEBS Lett 450: 6671.
  • Ohata K, Hamasaki K, Toriyama K, Ishikawa H, Nakao K, Eguchi K. 2004. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 19: 670675.
  • Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M. 1990. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 64: 12981303.
  • Okamoto H, Tsuda F, Akahane Y, Sugai Y, Yoshiba M, Moriyama K, Tanaka T, Miyakawa Y, Mayumi M. 1994. Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol 68: 81028110.
  • Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T, Okanoue T, Yotsuyanagi H, Iino S. 2001. A case-control study for clinical and molecular biological differences between hepatitis B viruses of genotypes B and C. Hepatology 33: 218223.
  • Realdi G, Alberti A, Rugge M, Bortolotti F, Rigoli AM, Tremolada F, Ruol A. 1980. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B infection. Gastroenterology 79: 195199.
  • Rokuhara A, Tanaka E, Matsumoto A, Kimura T, Yamaura T, Orii K, Sun X, Yagi S, Maki N, Kiyosawa K. 2003. Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment. J Viral Hepatitis 10: 17.
  • Takahashi K, Aoyama K, Ohno N, et al. 1995. The precore/core promoter mutant (T1762A1764) of hepatitis B virus: Clinical significance and an easy method for detection. J Gen Virol 76: 31593164.
  • Yamaura T, Tanaka E, Matsumoto A, Rokuhara A, Orii K, Yoshizawa K, Miyakawa Y, Kiyosawa K. 2003. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA Levels and mutations in the precore region and core promoter. J Med Virol 70: 545552.